文献速递免疫规划传染病防控与疫情报告

养老院居民中及时接种新冠疫苗预防SARS-CoV-2感染的效果——美国,2022年11月20日至2023年1月8日

Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents - United States, November 20, 2022-January 8, 2023.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2023-06-23

基于国家医疗安全网络2022年11月20日至2023年1月8日养老院新冠数据,分析及时接种疫苗(对比未及时接种)对实验室确诊SARS-CoV-2感染的效果。调整日历周、县新冠发病率、县社会脆弱性指数和机构员工及时接种比例后,及时接种疫苗有效性为31.2%(95%CI=29.1%-33.2%)。养老院居民应及时接种适龄新冠疫苗。

要点

  • 及时接种新冠疫苗对养老院居民SARS-CoV-2感染的有效性为31.2%(95%CI=29.1%-33.2%)。
  • 分析调整了日历周、县发病率、县社会脆弱性指数和机构员工及时接种比例。
  • 养老院居民应及时接种适龄新冠疫苗,包括≥65岁中重度免疫缺陷成人额外接种二价疫苗。

核心结论

  • 及时接种新冠疫苗对养老院居民实验室确诊SARS-CoV-2感染的有效性为31.2%(95%CI=29.1%-33.2%)。
  • 养老院居民应及时接种推荐适龄新冠疫苗,包括≥65岁中重度免疫缺陷成人额外接种二价疫苗以增强防护。

研究设计与样本

  • 分析国家医疗安全网络2022年11月20日至2023年1月8日报告的养老院新冠数据,比较及时接种与未及时接种状态。
  • 及时接种定义为接种二价新冠mRNA疫苗剂量或完成基础系列后2个月内。
  • 调整日历周、县新冠发病率、县社会脆弱性指数和机构员工及时接种比例。

主要发现

  • 及时接种疫苗对实验室确诊SARS-CoV-2感染的有效性为31.2%(95%CI=29.1%-33.2%)。

关键数值与推荐

  • 及时接种定义:接种二价新冠mRNA疫苗剂量或完成基础系列后2个月内。
  • 疫苗有效性31.2%(95%CI=29.1%-33.2%)为调整后及时接种对比未及时接种的感染防护效果。

临床怎么用

  • 养老院居民应及时接种推荐适龄新冠疫苗。
  • ≥65岁中重度免疫缺陷成人应及时接种额外二价疫苗剂量以增强防护。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nursing home residents have been disproportionately affected by the COVID-19 pandemic; their age, comorbidities, and exposure to a congregate setting has placed them at high risk for both infection and severe COVID-19-associated outcomes, including death (1). Receipt of a primary COVID-19 mRNA vaccination series (2) and monovalent booster doses (3) have been demonstrated to be effective in reducing COVID-19-related morbidity and mortality in this population. Beginning in October 2022, the National Healthcare Safety Network (NHSN) defined up-to-date vaccination as receipt of a bivalent COVID-19 mRNA vaccine dose or completion of a primary series within the preceding 2 months.* The effectiveness of being up to date with COVID-19 vaccination among nursing home residents in preventing SARS-CoV-2 infection is not known. This analysis used NHSN nursing home COVID-19 data reported during November 20, 2022-January 8, 2023, to describe effectiveness of up-to-date vaccination status (versus not being up to date) against laboratory-confirmed SARS-CoV-2 infection among nursing home residents. Adjusting for calendar week, county-level COVID-19 incidence, county-level social vulnerability index (SVI), and facility-level percentage of staff members who were up to date, up-to-date vaccine effectiveness (VE) against infection was 31.2% (95% CI = 29.1%-33.2%). Nursing home residents should stay up to date with recommended age-appropriate COVID-19 vaccination, which now includes an additional bivalent vaccine dose for moderately or severely immunocompromised adults aged ≥65 years to increase protection against SARS-CoV-2 infection.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Wong E, Barbre K, Wiegand RE, et al. Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents - United States, November 20, 2022-January 8, 2023. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37347711. doi:10.15585/mmwr.mm7225a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。